|
We asked 40 pharma leaders, how optimistic are you about revenue growth in 2013?
| Very optimistic |
39% |
Somewhat optimistic |
33% |
| Not optimistic at all |
28% |
 |
|
|
|
|
|
|
|
16 April, 2013
|
| In this Issue |
England's Cancer Drug Fund: The Acid Test for Value Based Pricing
England’s Cancer Drugs Fund (CDF) could be in its final financial year, after running in full since April 2011. It is supposed to be a ‘bridge’ to Value-Based Pricing (VBP), due to be implemented in January 2014. So, has it worked? ...Read more |
UK Doctors Paid £40 Million by Pharma Last Year
As part of its ongoing transparency drive, the Association of the British Pharmaceutical Industry confirms that, last year, doctors in the UK received approximately £40 million from Big Pharma ... Read more |
Read the New Pharm Exec Global Digest
In the April issue: Pharm Exec’s Brand of the Year; Successful Pull Marketing; Are US and Canadian Healthcare Policies Converging; and Is European Healthcare Failing Patients? ... Read more
|
A World Without Polio by 2018?
According to more than 400 eminent scientists and public health experts from around the world, an end to polio is scientifically feasible and achievable by 2018 ... Read more
|
The Product Manager's Marketing Handbook
Learn how to create a brand positioning statement, build brand value and turn business information into action. Strategy game planning — a competitive intelligence tool for pharma brand and product managers. Get tips on creating an effective launch plan ... Read more
|
|
|
|
